| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.09 | 0.5 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |